17 March 2022 - A House committee will spotlight an FDA process that’s been criticised as putting some of the ...
3 March 2022 - EMA’s PRIority Medicines (PRIME) scheme has had a positive impact on the authorisation of new medicines that ...
16 February 2022 - Consultation paper #3 A modernised fit for purpose listing process was released on 11 January and closes ...
14 February 2022 - Ensuring high quality, affordable generic drugs are available to the American public. ...
15 February 2022 - In 2021, EMA recommended 92 medicines for marketing authorisation. Of these, 53 had a new active substance ...
11 February 2022 - EMA’s safety committee, PRAC, has started a review of the safety of Janus kinase (JAK) inhibitors ...
10 February 2022 - Following consultation with members – and heeding the concerns of the Consumers Health Forum and patient ...
8 February 2022 - The consultation period on the draft NMP was due to close on Wednesday 16 February 2022. ...
4 February 2022 - Medicines Australia is today calling for the new National Medicines Policy to be pushed back until ...
31 January 2022 - NICE has published a new Manual, which sets out how the latest medicines and health technologies ...
2 February 2022 - Since August 2021, the Committee has heard from nearly 200 stakeholders through bilateral interviews and virtual group ...
31 January 2022 - Changes to the way medicines and other health technologies are evaluated by NICE have now been incorporated ...
28 January 2022 - Measuring and valuing health-related quality of life in children can be challenging but is an important component ...
21 January 2022 - On 30 August 2021, the National Medicines Policy Review Committee invited submissions to support the Review of ...
19 January 2022 - NICE also aims to make strides in digital, genomic and antimicrobial technologies ...